信邦控股(01571.HK):集團大部分美國客戶均已同意承擔全部或大部分近期新徵美國關稅
格隆匯5月22日丨信邦控股(01571.HK)公告,董事會欣然宣佈,集團大部分美國客戶均已同意承擔全部或大部分近期新徵的美國關稅。
集團經過與各美國客戶積極洽談,已成功安排部分客戶的產品製造流程遷移至其位於墨西哥和馬來西亞的生產設施。同時,還配合客戶將交付地轉移至墨西哥境內,以避免受到美國關稅的影響。2025年5月開始,部分原來在中國製造的產品已開始從集團的墨西哥工廠生產並交付。
公司將繼續密切關注事態發展,並將在適當的時候採取措施,盡力減輕美國關稅對集團業務與運營的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.